Detalhe da pesquisa
1.
Heat and Cardiovascular Mortality: An Epidemiological Perspective.
Circ Res
; 134(9): 1098-1112, 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662866
2.
Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease.
Int J Mol Sci
; 24(18)2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762446
3.
Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries.
J Intern Med
; 291(3): 327-337, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820922
4.
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.
Am Heart J
; 231: 96-104, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203618
5.
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Heart Fail Rev
; 26(6): 1421-1435, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314085
6.
Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
Circulation
; 139(18): e891-e908, 2019 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30913893
7.
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale.
Gerontology
; 66(5): 447-459, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610336
8.
Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
Am Heart J
; 215: 83-90, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291604
9.
Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.
Clin Chem
; 65(8): 1023-1030, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072836
10.
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.
Am J Ther
; 26(6): e671-e678, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31145139
11.
Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate.
Eur Heart J Suppl
; 21(Suppl A): A28-A33, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30837802
12.
Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated.
Eur Heart J
; 44(42): 4485-4487, 2023 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862581
13.
Toward personalized medicine for cardiovascular pharmacotherapy.
Eur Heart J
; 43(45): 4719-4721, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924414
14.
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
Eur Heart J
; 43(37): 3512-3527, 2022 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925556
15.
Automatic identification of variables in epidemiological datasets using logic regression.
BMC Med Inform Decis Mak
; 17(1): 40, 2017 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407816
16.
Fluoroquinolone use and valvular heart disease: is the jury still out?
Eur Heart J
; 42(30): 2909-2911, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254116
17.
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.
Ann Intern Med
; 163(1): 40-51, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25915661
18.
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Eur Heart J
; 41(3): 407-477, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504439
19.
Medical Misinformation.
Circulation
; 139(5): 571-572, 2019 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689419
20.
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Am Heart J
; 169(2): 257-265.e1, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25641535